| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |